Exploring the Impact of Leucocyte Ig-like Receptor B1 on TNIP1 Protein  Expression in Immune Effector Cells

Murad Ali, Tania Khattak, Azka Afzal, Akhtar Nawab, Isma Ali, Fawad Khalid

Exploring the Impact of Leucocyte Ig-like Receptor B1 on TNIP1 Protein Expression in Immune Effector Cells

Authors

Murad Ali, Tania Khattak, Azka Afzal, Akhtar Nawab, Isma Ali, Fawad Khalid

Keywords:

LILRB1, TNIP1, immune effector cells, flow cytometry, inhibitory receptor, immune regulation

Abstract

Background: Leucocyte Immunoglobulin-like Receptor B1 (LILRB1), also known as Immunoglobulin-like Transcript 2 (ILT2) or CD85j, is an inhibitory receptor that plays a crucial role in regulating immune effector cell activity. LILRB1 exerts its inhibitory function through Immunoreceptor Tyrosine-based Inhibitory

References

Allanore, Y., Saad, M., Dieudé, P., Avouac, J., & Distler, J. H. W. (2011). Genome-Wide Scan Identifies TNIP1. PSORS1C1, and RHOB As Novel Risk Loci for.

Hou, H. W., Bhagat, A. A. S., Lee, W. C., Huang, S., Han, J., & Lim, C. T. (2011). Microfluidic devices for blood fractionation. Micromachines, 2(3), 319-343.

Downloads

Published

2025-10-06

How to Cite

Murad Ali, Tania Khattak, Azka Afzal, Akhtar Nawab, Isma Ali, Fawad Khalid. (2025). Exploring the Impact of Leucocyte Ig-like Receptor B1 on TNIP1 Protein Expression in Immune Effector Cells . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2369–2381. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1060